Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...

The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...

Mumbai: For weeks, a shortage of cartridges for rapid tuberculosis tests has hampered the city's ability to diagnose ...

Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one ...

A research team led by Senior Researcher Chanyong Park, Principal Researcher Dongkyu Lee, and Postdoctoral Researcher Changha ...

Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid ...

Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction claim for the KingFishertm Flex Nucleic Acid Purification System ...

Surat: Surat Raktdan Kendra and Research Centre (SRKRC) has upgraded its Nucleic Acid Testing (NAT) system, further strengthening the safety of blood .

Abstract: Nucleic Acid Amplification Tests (NAATs) are used to diagnose infectious diseases such as tuberculosis (TB), SARS-CoV-2, and Human Papillomavirus (HPV). Conventional testing requires a bench ...

We searched for evidence from studies known as 'clinical trials' that compared rapid TB tests with traditional methods of testing for TB, like smear microscopy and culture. We summarised the findings ...

CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex ...